Application 021551

Type
NDA
Sponsor
BRAINTREE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002HALFLYTELYBISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDEFOR SOLUTION, TABLET, DELAYED RELEASE;ORAL5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GMNoNo
003HALFLYTELYBISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDEFOR SOLUTION, TABLET, DELAYED RELEASE;ORAL5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
5725SUPPL2011-07-12
43769ORIG2010-07-30
5724SUPPL2010-07-23
15773SUPPL2010-07-19
37213SUPPL2007-09-26
5723SUPPL2007-09-26
15772SUPPL2006-05-22
28104SUPPL2006-05-21
42209ORIG2005-12-01
5722SUPPL2005-03-03
15771ORIG2004-05-27
28103ORIG2004-05-26
53287ORIG1900-01-01
53286ORIG1900-01-01
53285ORIG1900-01-01